These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2852064)

  • 1. Inhibition of human endothelial cell proliferation by heparin and steroids.
    Cariou R; Harousseau JL; Tobelem G
    Cell Biol Int Rep; 1988 Dec; 12(12):1037-47. PubMed ID: 2852064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
    Khorana AA; Sahni A; Altland OD; Francis CW
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-steroid conjugates lacking glucocorticoid or mineralocorticoid activities inhibit the proliferation of vascular endothelial cells.
    Derbyshire EJ; Yang YC; Li S; Comin GA; Belloir J; Thorpe PE
    Biochim Biophys Acta; 1996 Jan; 1310(1):86-96. PubMed ID: 9244180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins.
    Hämmerle H; Betz E; Herr D
    Vasa; 1991; 20(3):207-15. PubMed ID: 1659056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
    Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
    Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation: in vitro evaluation with soluble and crosslinked polysaccharide matrices.
    Letourneur D; Machy D; Pellé A; Marcon-Bachari E; D'Angelo G; Vogel M; Chaubet F; Michel JB
    J Biomed Mater Res; 2002 Apr; 60(1):94-100. PubMed ID: 11835164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
    Blei F; Wilson EL; Mignatti P; Rifkin DB
    J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue.
    Shireman PK; Xue L; Maddox E; Burgess WH; Greisler HP
    J Vasc Surg; 2000 Feb; 31(2):382-90. PubMed ID: 10664506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions.
    Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Vasc Surg; 1999 May; 29(5):852-61; discussion 862. PubMed ID: 10231637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin inhibits the progression phase of subcultured endothelial cell proliferation in rat aorta.
    Kimura I; Nagaura T; Naitoh T; Kobayashi S; Kimura M
    Jpn J Pharmacol; 1992 Dec; 60(4):369-75. PubMed ID: 1287272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
    Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
    Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenicity and release of vascular endothelial growth factor with and without heparin from fibrin glue.
    Shireman PK; Greisler HP
    J Vasc Surg; 2000 May; 31(5):936-43. PubMed ID: 10805884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfated polysaccharides modulate effects of acidic and basic fibroblast growth factors on repair of injured confluent human vascular endothelium.
    Klein-Soyer C; Beretz A; Cazenave JP; Wittendorp-Rechenmann E; Vonesch JL; Rechenmann RV; Driot F; Maffrand JP
    Arteriosclerosis; 1989; 9(2):147-53. PubMed ID: 2466455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sera, basic fibroblast growth factor, heparin and cyclic AMP-stimulation on proliferation of human vascular endothelial cells.
    Gillis C; Jonzon B; Haegerstrand A
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1131-8. PubMed ID: 8747094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
    Lupu C; Poulsen E; Roquefeuil S; Westmuckett AD; Kakkar VV; Lupu F
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.
    Chen NT; Corey EJ; Folkman J
    Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
    Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
    Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biointeractive polymers and tissue engineered blood vessels.
    Greisler HP; Gosselin C; Ren D; Kang SS; Kim DU
    Biomaterials; 1996 Feb; 17(3):329-36. PubMed ID: 8745330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the effect of vascular endothelial growth factor on endothelial cells by heparin: critical role of nitric oxide-mediated mechanisms.
    Yagüe S; Alvarez Arroyo V; Castilla A; González Pacheco FR; Llamas P; Caramelo C
    J Nephrol; 2005; 18(3):234-42. PubMed ID: 16013009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.